Rapid Ebola testing: FDA allows marketing of OraQuick Ebola Rapid Antigen Test
by Press Release from Outbreak News Today on (#4S9JW)
The U.S. Food and Drug Administration allowed marketing of a rapid diagnostic test (RDT) to detect Ebola virus antigens (proteins) in human blood from certain living individuals and samples from certain recently deceased individuals suspected to have died from Ebola (cadaveric oral fluid). The OraQuick Ebola Rapid Antigen Test is the first rapid diagnostic test ["]
The post Rapid Ebola testing: FDA allows marketing of OraQuick Ebola Rapid Antigen Test appeared first on Outbreak News Today.